| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.13 | 0.5 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |